2023 National Alzheimer's Summit

Learn how one action-oriented family is making an impact on preventing Alzheimer’s. David Dolby, of the Dolby Foundation and Dolby Investments, shares his insights on advancements in the field and how families experiencing the disease can be the moral force of change.

The treatment of Alzheimer’s continues to improve. As new therapies are approved by the FDA, doctors have more options for their patients, leading to better and more patient-centered care. Ideally, a patient who has a concern about their cognition will see their primary care physician, have the confidence to raise the concern, be screened for potential impairment, and if appropriate be referred to a physician with the skill, experience, and infrastructure to consider this patient for a new Alzheimer’s therapy. Key Question: What steps are leading clinicians and health systems taking to ensure that each Alzheimer’s patient who qualifies gets the right drug and in time to make a difference?

Proactive, precision, whole health medicine is the next frontier in healthcare. What does this mean for Alzheimer’s? Learn how advances in technology, lifestyle medicine, and preventive therapeutics help not only prevent chronic conditions like heart disease and diabetes but also maintain cognition into older years. It is never too early to talk about brain health. Key Question: How are the latest approaches and cutting-edge modalities giving health professionals an edge against Alzheimer’s?

We talk with a distinguished champion of the Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act about its progress and ramifications. Hear what Sen. Capito thinks needs to happen from a government perspective to equip providers with the tools they need to accurately detect and diagnose Alzheimer’s at its earliest stages.